Then, CD133+ and CD133− cells were sorted via MACS in three HCC cell lines, including HCC-LY5, SMMC-7721 and MHCC-LM3, which had low expression of CD133 (Supplementary Fig. S3A)6. This evidence concerns the gene PROM1 and hepatocellular carcinoma.